Literature DB >> 11823977

Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps.

Franz Fogt1, Thomas Brien, Charlotte A Brown, Christopher J Hartmann, Robert L Zimmerman, Robert D Odze.   

Abstract

Serrated adenoma is a recently described entity characterized by the presence of a hyperplastic (serrated) growth pattern combined with cytologic features of dysplasia. In contrast to conventional (nonserrated) adenomas, the molecular features of serrated adenomas have been poorly studied. Thus, it remains unclear if serrated adenomas are simply a morphologic variant of conventional adenomas or represent a different biologic entity. In this study, 46 serrated adenomas from 39 patients, 32 conventional (nonserrated) adenomas from 31 patients, and 18 hyperplastic polyps from 16 patients were evaluated for loss of heterozygosity (LOH) of APC, p53, p16, and 3p and for K-ras mutations of codons 12, 13, and 61 by polymerase chain reaction (PCR) analysis. Serrated adenomas demonstrated LOH of at least one genetic locus in 32.6% of cases. LOH of the APC gene, 3p, p53, and p16 was seen in 19.4%, 14.2%, 9.3%, and 13.8% of cases, respectively. K-ras mutations were observed in 18% of cases. Similar to serrated adenomas, conventional adenomas demonstrated at least one LOH event in 37.5% of cases and K-ras mutations in another 19% of cases. LOH of APC, 3p, p53, and p16 was observed in 22%, 33%, 5.8%, and 13.4% of cases, respectively. There were no significant differences in either the total number of genetic events or the presence of LOH of any of the individual markers between serrated adenomas and conventional adenomas. However, hyperplastic polyps showed LOH in 22% of cases and a single K-ras mutation (11%). The prevalence of LOH in hyperplastic polyps was lower than both serrated adenomas and conventional adenomas (P < .05). These results support the hypothesis that serrated adenomas represent a biologically similar morphologic variant of conventional adenomas. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823977     DOI: 10.1053/hupa.2002.30377

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Molecular validation of the modified Vienna classification of colorectal tumors.

Authors:  Tamotsu Sugai; Wataru Habano; Noriyuki Uesugi; Yu-Fei Jiao; Shin-ichi Nakamura; Kimihiko Sato; Toshimi Chiba; Motohiro Ishii
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

2.  Frequent CpG island methylation in serrated adenomas of the colorectum.

Authors:  Seun-Ja Park; Asif Rashid; Jae-Hyuk Lee; Sang Geol Kim; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual.

Authors:  P Zauber; M Sabbath-Solitare; S Marotta; A Zauber; T Bishop
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

4.  Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families.

Authors:  S H Andersen; E Lykke; M B Folker; I Bernstein; S Holck
Journal:  Fam Cancer       Date:  2007-10-10       Impact factor: 2.375

5.  Serrated polyposis: an enigmatic model of colorectal cancer predisposition.

Authors:  Christophe Rosty; Susan Parry; Joanne P Young
Journal:  Patholog Res Int       Date:  2011-05-30

6.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.

Authors:  J R Jass; K Baker; I Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

7.  Serrated Adenoma of Gastric Antrum: Alteration of Mucin Expression Profile and its Role in Carcinogenesis.

Authors:  Yesim Gurbuz; Cem Aygun; Gupse Turan
Journal:  Gastroenterology Res       Date:  2009-05-20

8.  Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1.

Authors:  Mandy Schneider; Bettina Scholtka; Uwe Gottschalk; Siegbert Faiss; Daniela Schatz; Kornelia Berghof-Jäger; Pablo Steinberg
Journal:  Cancers (Basel)       Date:  2010-12-29       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.